Cue Biopharma appoints James Ahlers as CFO
CUE•CFO appointment
Cue Biopharma named James M. Ahlers chief financial officer, reporting to CEO Shao-Lee Lin.
Ahlers previously spent nearly two decades as CFO of Intarcia Therapeutics, scaling finance operations through a period of growth.
He most recently worked as a consulting CFO and strategic adviser to emerging biotech companies, focusing on financing strategy and SEC reporting.
